Works matching IS 13520504 AND DT 2022 AND VI 29 AND IP 9
Results: 15
Real‐world study on HBsAg loss of combination therapy in HBeAg‐negative chronic hepatitis B patients.
- Published in:
- Journal of Viral Hepatitis, 2022, v. 29, n. 9, p. 765, doi. 10.1111/jvh.13722
- By:
- Publication type:
- Article
Extrahepatic carcinogenicity of oral nucleos(t)ide analogues in chronic hepatitis B carriers: A 35,000‐Korean outcome study.
- Published in:
- Journal of Viral Hepatitis, 2022, v. 29, n. 9, p. 756, doi. 10.1111/jvh.13721
- By:
- Publication type:
- Article
Frequent alanine aminotransferase flares and promising antiviral therapy efficacy during the preschool age: An opportunity to achieve HBsAg loss in children with mother‐to‐child transmitted hepatitis B.
- Published in:
- Journal of Viral Hepatitis, 2022, v. 29, n. 9, p. 748, doi. 10.1111/jvh.13720
- By:
- Publication type:
- Article
Progress towards the elimination of hepatitis B in children in Colombia: A novel two‐phase study approach.
- Published in:
- Journal of Viral Hepatitis, 2022, v. 29, n. 9, p. 737, doi. 10.1111/jvh.13719
- By:
- Publication type:
- Article
Follow‐up evaluation of patients with liver test abnormalities detected during SARS‐CoV2 infection.
- Published in:
- Journal of Viral Hepatitis, 2022, v. 29, n. 9, p. 823, doi. 10.1111/jvh.13718
- By:
- Publication type:
- Article
International multicenter validation of GES score for HCC risk stratification in chronic hepatitis C patients.
- Published in:
- Journal of Viral Hepatitis, 2022, v. 29, n. 9, p. 807, doi. 10.1111/jvh.13717
- By:
- Publication type:
- Article
Sustainable and equivalent improvements in symptoms and functional well‐being following viral cure from ledipasvir/sofosbuvir versus elbasvir/grazoprevir for chronic hepatitis C infection: Findings from the randomized PRIORITIZE trial.
- Published in:
- Journal of Viral Hepatitis, 2022, v. 29, n. 9, p. 795, doi. 10.1111/jvh.13716
- By:
- Publication type:
- Article
Posttreatment nonalcoholic fatty liver disease fibrosis scores for predicting liver‐related complications in patients with chronic hepatitis C receiving direct‐acting antiviral agents.
- Published in:
- Journal of Viral Hepatitis, 2022, v. 29, n. 9, p. 785, doi. 10.1111/jvh.13715
- By:
- Publication type:
- Article
Hepatitis E case series: A UK experience.
- Published in:
- Journal of Viral Hepatitis, 2022, v. 29, n. 9, p. 817, doi. 10.1111/jvh.13714
- By:
- Publication type:
- Article
Mortality and cause of death in persons with chronic hepatitis B virus infection versus healthy persons from the general population in Denmark.
- Published in:
- Journal of Viral Hepatitis, 2022, v. 29, n. 9, p. 727, doi. 10.1111/jvh.13713
- By:
- Publication type:
- Article
A morphometric analysis of hepatitis B subviral particles shows no correlation of filament proportion and length with clinical stage and genotype.
- Published in:
- Journal of Viral Hepatitis, 2022, v. 29, n. 9, p. 719, doi. 10.1111/jvh.13712
- By:
- Publication type:
- Article
Epidemiology and treatment of hepatitis E in the liver transplantation setting: A literature review.
- Published in:
- Journal of Viral Hepatitis, 2022, v. 29, n. 9, p. 698, doi. 10.1111/jvh.13709
- By:
- Publication type:
- Article
Hepatitis C hospitalizations in Spain and impact of new curative antiviral therapies.
- Published in:
- Journal of Viral Hepatitis, 2022, v. 29, n. 9, p. 777, doi. 10.1111/jvh.13708
- By:
- Publication type:
- Article
Evaluating the prevalence of Hepatitis E virus infection in a large cohort of European blood donors, 2015–2018.
- Published in:
- Journal of Viral Hepatitis, 2022, v. 29, n. 9, p. 835, doi. 10.1111/jvh.13682
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Journal of Viral Hepatitis, 2022, v. 29, n. 9, p. 695, doi. 10.1111/jvh.13539
- Publication type:
- Article